GlassScriptPhysician profile
Mark J Shen
NPI 1346539467
$40,868.71
in general payments reported to CMS, 2019-2025
31 companies · $4,454 in 2025
The $4,454 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,281 · 2020: $1,210 · 2021: $5,547 · 2022: $3,440 · 2023: $12K · 2024: $4,930 · 2025: $4,454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,288 · Travel and Lodging: $3,819 · Honoraria: $1,750 · Consulting Fee: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,058.82 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,288.00 |
| Travel and Lodging | $3,818.88 |
| Honoraria | $1,750.00 |
| Consulting Fee | $475.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,137.51 | 2021-2025 | Micra, Na, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $6,373.59 | 2019-2025 | Watchman Access System, Farapulse, Watchman Flx |
| Abbott Laboratories | $5,869.65 | 2019-2025 | Ensite Precision, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Sanofi-Aventis U.S. LLC | $4,537.34 | 2022-2023 | |
| Medtronic Vascular, INC. | $4,306.53 | 2019-2020 | |
| Biotronik INC. | $3,935.05 | 2019-2025 | Acticor 7 Vr-T Dx, Biomonitor, Amvia Edge |
| Altathera Pharmaceuticals LLC | $2,950.56 | 2023 | Sotalol Hydrochloride |
| Biosense Webster, INC. | $1,044.80 | 2019-2025 | Nuvision Ice Catheter, Carto 3, Qdot Micro |
| E.R. Squibb & Sons, L.L.C. | $692.14 | 2019-2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $620.20 | 2021-2025 | Lifevest |
| Elutia, INC. | $400.38 | 2023-2025 | Ecm Patch,Pouch |
| Atricure, INC. | $363.71 | 2019-2024 | |
| Cvrx, INC. | $286.75 | 2023-2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $253.16 | 2023-2025 | Jardiance |
| Impulse Dynamics (USA) INC. | $213.71 | 2023-2025 | Optimizer, Optimizer |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $134.71 | 2023-2024 | Evolution |
| Astrazeneca Pharmaceuticals LP | $123.73 | 2024-2025 | Farxiga |
| Novartis Pharmaceuticals Corporation | $105.26 | 2022-2025 | |
| Cardiva Medical, INC. | $94.17 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Janssen Scientific Affairs, LLC | $86.48 | 2024 | Xarelto |
| Pfizer INC. | $86.14 | 2022-2025 | |
| Becton, Dickinson and Company | $45.00 | 2024 | Bd Introsyte |
| Welch Allyn | $42.38 | 2019 | |
| Edwards Lifesciences Corporation | $36.03 | 2024 | Sapien 3 Ultra Resilia |
| Abiomed | $34.89 | 2025 | |
| Terumo Medical Corporation | $22.23 | 2025 | Angio-Seal |
| Amgen INC. | $20.03 | 2022 | |
| Convatec INC. | $19.82 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $16.85 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.91 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Shen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.